PF-00562271

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
0120082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Retinal gene therapy based on adeno-associated viral (AAV) vectors is safe and efficient in humans. The low intrinsic DNA… (More)
Is this relevant?
2017
2017
BACKGROUND/AIMS Istaroxime is a validated inotropic Na+/K+ ATPase inhibitor currently in development for the treatment of various… (More)
Is this relevant?
Review
2015
Review
2015
Focal adhesion kinase (FAK) is a key regulator of growth factor receptor- and integrin-mediated signals, governing fundamental… (More)
  • table 1
Is this relevant?
2014
2014
Docetaxel remains the standard-of-care for men diagnosed with metastatic castrate-resistant prostate cancer (CRPC). However, only… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Docetaxel remains the standard-of-care formen diagnosedwithmetastatic castrate-resistant prostate cancer (CRPC). However, only… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE PF-00562271 is a novel inhibitor of focal adhesion kinase (FAK). The objectives of this study were to identify the… (More)
Is this relevant?
Review
2008
Review
2008
This review summarizes phase I trial results of 11 drugs presented at the American Society of Clinical Oncology meeting held in… (More)
  • table 1
  • table 1
Is this relevant?